KNSA
Kiniksa Pharmaceuticals, Ltd.
NASDAQ · BMHealthcareBiotechnology
$63.38-0.90%
Price as of Jul 20, 2026
KNSA ownership
Kiniksa Pharmaceuticals, Ltd. ownership & insider activity
Latest available institutional positioning and SEC Form 4 insider transactions, coalesced at the company entity level when listings share coverage.
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
9
Net (3m)
-$31.6M
Insider trades by month Buys Sells
Dec
Jan
Feb
Mar
Apr
May
Context3-month price +36.1%Institutions mixed (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 6, 2026 | Malkani Dhiraj Hofficer: CHIEF STRATEGY OFFICER | Grant | 14,000 | — |
| Jul 6, 2026 | Malkani Dhiraj Hofficer: CHIEF STRATEGY OFFICER | Grant | 2,188 | $62.88 |
| Jul 6, 2026 | Malkani Dhiraj Hofficer: CHIEF STRATEGY OFFICER | Grant | 82,600 | $62.88 |
| Jul 6, 2026 | Malkani Dhiraj Hofficer: CHIEF STRATEGY OFFICER | Grant | 1,307 | — |
| Jun 2, 2026 | Malley Thomasdirector | Grant | 12,158 | $48.38 |
| Jun 2, 2026 | Quart Barry Ddirector | Grant | 2,026 | — |
| Jun 2, 2026 | McCain Tracey Ldirector | Option | 2,799 | — |
| Jun 2, 2026 | BAKER BROS. ADVISORS LPdirector | Grant | 36,474 | $48.38 |
| Jun 2, 2026 | McCain Tracey Ldirector | Grant | 12,158 | $48.38 |
| Jun 2, 2026 | BAKER BROS. ADVISORS LPdirector | Grant | 6,078 | — |
| Jun 2, 2026 | Popovits Kimberly Jdirector | Option | 2,799 | — |
| Jun 2, 2026 | Levy Richard Sdirector | Grant | 12,158 | $48.38 |
| Jun 2, 2026 | Cole G Bradleydirector | Grant | 12,158 | $48.38 |
| Jun 2, 2026 | Cole G Bradleydirector | Option | 2,799 | — |
| Jun 2, 2026 | Malley Thomasdirector | Grant | 2,026 | — |
| Jun 2, 2026 | Malley Thomasdirector | Option | 2,799 | — |
| Jun 2, 2026 | Levy Richard Sdirector | Option | 2,799 | — |
| Jun 2, 2026 | McCain Tracey Ldirector | Grant | 2,026 | — |
| Jun 2, 2026 | Quart Barry Ddirector | Grant | 12,158 | $48.38 |
| Jun 2, 2026 | Popovits Kimberly Jdirector | Grant | 2,026 | — |
| Jun 2, 2026 | Levy Richard Sdirector | Grant | 2,026 | — |
| Jun 2, 2026 | Popovits Kimberly Jdirector | Grant | 12,158 | $48.38 |
| Jun 2, 2026 | Cole G Bradleydirector | Grant | 2,026 | — |
| Jun 2, 2026 | Quart Barry Ddirector | Option | 2,799 | — |
| May 5, 2026 | Paolini John F.officer: CHIEF MEDICAL OFFICER | Option | 58,424 | $10.36 |
| May 5, 2026 | Paolini John F.officer: CHIEF MEDICAL OFFICER | Sell | 37,327 | $53.52 |
| May 5, 2026 | Paolini John F.officer: CHIEF MEDICAL OFFICER | Sell | 21,097 | $54.04 |
| May 1, 2026 | Patel Sanj Kdirector, officer: CHAIRMAN & CEO | Sell | 48,565 | $54.02 |
| May 1, 2026 | Patel Sanj Kdirector, officer: CHAIRMAN & CEO | Option | 48,565 | $30.93 |
| Apr 30, 2026 | Patel Sanj Kdirector, officer: CHAIRMAN & CEO | Option | 431,904 | $10.36 |
Source: KNSA SEC Form 4 filings, latest Jul 6, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their KNSA positions over the last 6 months (SEC Form 13F).
Increased
161
New positions
81
Reduced
155
Sold out
57
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| FMR LLC | Increased | 6.8M | May 15, 2026 |
| RUBRIC CAPITAL MANAGEMENT LP | Increased | 3.8M | May 15, 2026 |
| RUBRIC CAPITAL MANAGEMENT LP | Reduced | 3.3M | Feb 13, 2026 |
| VANGUARD GROUP INC | Increased | 3.1M | Jan 29, 2026 |
| BAKER BROS. ADVISORS LP | Increased | 2.8M | Feb 17, 2026 |
| BAKER BROS. ADVISORS LP | Unchanged | 2.8M | May 15, 2026 |
| TANG CAPITAL MANAGEMENT LLC | Unchanged | 2.3M | May 15, 2026 |
| TANG CAPITAL MANAGEMENT LLC | Reduced | 2.3M | Feb 17, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 1.8M | May 8, 2026 |
| ACADIAN ASSET MANAGEMENT LLC | Increased | 1.7M | Feb 10, 2026 |
| FMR LLC | Increased | 1.6M | Feb 17, 2026 |
| CAPTION MANAGEMENT, LLC | Increased | 1.5M | Feb 17, 2026 |
| MORGAN STANLEY | Reduced | 1.4M | Feb 13, 2026 |
| ACADIAN ASSET MANAGEMENT LLC | Reduced | 1.3M | May 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 1.3M | May 15, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.